← Leaderboards
David M Goldenberg
Ctr For Molecular Medicine/Immunology
$649,937
Attributed
$649,937
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–09$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$10,957,614 · 10
By mechanism
P01$10,398,608 · 5
R01$435,005 · 1
S07$100,000 · 1
R13$24,001 · 3
Top collaborators
No co-investigators on record.
Most similar at Ctr For Molecular Medicine/Immunology
Same institution · by research overlap
- Robert M Sharkey$7,941,617
- Rosalyn D Blumenthal$4,498,008
- David V Gold$4,477,124
- M Jules Mattes$1,208,134
Others in their field
Top investigators on “Immunoconjugates”
- Edward A Neuwelt · Oregon Health And Science University$8,971,593
- Rakesh K. Jain · Massachusetts General Hospital$8,290,808
- Kim D Janda · Scripps Research Institute$8,002,711
- Brian Matthew Zeglis · Sloan-Kettering Inst Can Research$4,383,787
- Darell D Bigner · Duke University$4,368,080
- Bogdan Olenyuk · California Institute Of Technology$3,812,988
Research focus
ImmunoconjugatesClinical ResearchAntibodiesImmunotherapyProgramsPre-ClinicalTravelNeoplasm /Cancer ImmunotherapyMeeting /Conference /SymposiumRadioimmunoconjugateCollaborationsClinical TrialsPreclinical StudyAreaRadiolabeledNeoplasm /Cancer RadioimmunotherapyAntibodyNeoplasm /Cancer TherapyCd22 GeneB Lymphoid MalignancyMultiple MyelomaHuman Therapy EvaluationImmunoglobulin GInterest
Grant awards (17)
Targeted Therapy of B-cell Malignancies$519,832
P01 · FY2009 · CA · contact PI
Targeted Therapy of B-cell Malignancies$1,618,062
P01 · FY2008 · CA · contact PI
Clinical Trials of NHL$90,931
P01 · FY2008 · CA · contact PI
11th & 12th Conference on Cancer Therapy with Antibodies and Immunoconjugates$5,000
R13 · FY2008 · CA · contact PI
Targeted Therapy of B-cell Malignancies$1,603,282
P01 · FY2007 · CA · contact PI
Targeted Therapy of B-cell Malignancies$1,604,348
P01 · FY2006 · CA · contact PI
11th & 12th Conference on Cancer Therapy with Antibodies and Immunoconjugates$5,000
R13 · FY2006 · CA · contact PI
Targeted Therapy of B-cell Malignancies$1,616,000
P01 · FY2005 · CA
9/10TH Conf./Cancer Therapy/Antibody/Immunoconjugates$5,000
R13 · FY2004 · CA
9/10TH Conf./Cancer Therapy/Antibody/Immunoconjugates$1
R13 · FY2003 · CA
CMMI Human Subject Research Enhancement Program$100,000
S07 · FY2002 · RR
9/10TH Conf./Cancer Therapy/Antibody/Immunoconjugates$5,000
R13 · FY2002 · CA
RADIOIMMUNOTHERAPY OF CANCER$3,346,153
P01 · FY2000 · CA
RADIOIMMUNOTHERAPY OF NONHODGKINS LYMPHOMA WITH LL2$435,005
R01 · FY2000 · CA
SCIENTIFIC MEETING, ADVANCES IN CANCER IMMUNOTHERAPY$4,000
R13 · FY2000 · CA
CORE--BIOSTATISTICS$0
P01 · FY2000 · CA
RADIOIMMUNOTHERAPY OF EPITHELIAL OVARIAN CANCER$0
P01 · FY2000 · CA